跳至主要内容
临床试验/NCT01183572
NCT01183572已完成不适用

Trial of Pre-Pregnancy Supplements

Harvard School of Public Health (HSPH)1 个研究点 分布在 1 个国家目标入组 802 人开始时间: 2010年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
802
试验地点
1
主要终点
Anemia

研究概览

简要总结

The purpose of this study is to determine whether daily oral supplements of multivitamins (including vitamins B-complex, C and E) along with Iron and folic acid given to non-pregnant women results in lower prevalence of anemia in preparation for pregnancy when compared to daily iron and folic acid supplements or folic acid alone.

详细描述

Globally, more than half a million women die from pregnancy or childbirth-related complications, most of them in developing countries. The global community committed to reducing the maternal mortality ratio by three quarters between 1990 and 2015 (MDG5). Women die from a range of complications in pregnancy, childbirth or the postpartum period. 80% of maternal deaths are due to severe bleeding (mostly bleeding postpartum), infections, hypertensive disorders in pregnancy and obstructed labor. Additionally, low birth weight and neonatal mortality are common problems in developing countries. The benefit of periconceptual folate on preventing congenital anomalies has been established in randomized trials; however, the role of other nutrients needs to be examined further. Anemia is strongly associated with adverse perinatal outcomes including maternal mortality and low birthweight.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 29 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Girls aged > =15 years and <= 29 years
  • Have not missed a menstrual period during recruitment (no amenorrhea)
  • Has not been pregnant or given birth within the last 6 months
  • Intend to stay in the study area for at least 6 months after enrollment
  • Have provided written informed consent

排除标准

  • Amenorrhea or confirmed pregnancy at screening or enrollment.
  • Has given birth within 6 months
  • Already taking long-term vitamin supplementation.
  • Any severe illness requiring hospitalization at screening or enrollment (women who have been deemed to have recovered will be eligible once they return home).

结局指标

主要结局

Anemia

时间窗: 6 months following the start of the intervention

Anemia will be defined as hemoglobin \< 12gm/dL at 6 months of intervention. Hemoglobin concentration will also be analyzed as a continuous outcome.

次要结局

  • Weight Gain during intervention(6 months following the start of the intervention)
  • Mid Upper Arm Circumference(6 months following the start of the intervention)
  • Peripheral malaria parasitemia(6 months following the start of the intervention)

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wafaie Fawzi

Chair, Department of Global Health and Population

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验

Trial of Pre-Pregnancy Supplements | 临床试验